Causal Inference from Complex Observa4onal Data. Samantha Kleinberg

Size: px
Start display at page:

Download "Causal Inference from Complex Observa4onal Data. Samantha Kleinberg"

Transcription

1 Causal Inference from Complex Observa4onal Data Samantha Kleinberg

2 Three key points We need causal knowledge Causes are hard to find It s not hopeless!

3 Most striking, society will need to shed some of its obsession for causality in exchange for simple correla4ons: not knowing why but only what. Mayer- Schonberger, V. and K. Cukier. (2013) Big Data: A Revolu3on That Will Transform How We Live, Work, and Think. Earnon Dolan/Houghton Mifflin Harcourt, (page 7).

4 Causal claims are everywhere

5 Why do we need causes? Predic4on Explana4on Interven4on

6 Predic4on Blackouts Season Smoking rate match sales lung cancer rate

7 Predic4on, con4nued Gene muta4on ê exercise tolerance Disease A

8 Explana4on (1) Why are two variables related? Diabetes CKD Blurred vision Weight loss Renal failure medica4on

9 Explana4on (2) General causes of illness vs. cause of a specific pa4ent s illness Why did an event happen? Why did a par4cular person develop lung cancer at age 42? What led to the U.S. recession in 2007? Is a stroke pa4ent s secondary brain injury due to seizures?

10 Automa4ng explana4on Methods for finding causes from data, but what about explaining events? Prac4cal problem, but challenging Informa4on incomplete Where do explana4ons come from? General and singular can differ Kleinberg (2013) Causality, Probability and Time

11 Interven4on Why do we need causes to take ac4on? Buying stocks Taking vitamins Decreasing sodium to prevent hypertension What happens if we intervene on a correlated factor?

12 Using causes to guide interven4on Blackouts Season Smoking rate match sales lung cancer rate

13 hdp://xkcd.com/552/

14 Correla4on without causa4on: nonsta4onary 4me series hdp://bama.ua.edu/~spren4c

15 AUTISM ORGANIC hdp://imgur.com/1wz6h

16 Correla4on without causa4on: hidden common causes

17 Correla4on without causa4on: mul4ple tes4ng Benned, C. M., Miller, M. B., & Wolford, G. L. (2009). Neural correlates of interspecies perspec4ve taking in the post- mortem atlan4c salmon: An argument for mul4ple comparisons correc4on. NeuroImage, 47(1), 125.

18 Mul4ple comparisons hdp://xkcd.com/882/

19 Causa4on without correla4on: Simpson s paradox Treatment Dead Alive A (72%) B (80%) Total

20 Causa4on without correla4on: Simpson s paradox Treatment Men Women Combined Dead Alive Dead Alive Dead Alive A (60%) 5 95 (95%) (72%) B (50%) (85%) (80%) Total Baker SG, Kramer BS (2001) Good for women, good for men, bad for people: Simpson's paradox and the importance of sex- specific analysis in observa4onal studies. Journal of women's health & gender- based medicine 10:

21 Hume Regularity Counterfactual Mill Mackie (INUS) Probabilis4c causality Lewis Granger causality Eells Suppes Reichenbach Logic- based Bayesian nets

22 Smoking x x Lung cancer Yellowed fingers y y Bayesian networks t t+1 [Pearl, 2000; Spirtes, Glymour and dynamic Bayesian networks Scheines, 2000] P(X t+1 W t ) P(X t+1 W t - Y t ) Granger causality [Granger, 1980]

23 Why is causal inference hard? No single defini4on No fail- proof method for finding it Observa4onal data

24 Philosophy: What is a cause?

25 Philosophy: What is a cause? Computer Science: How can we automate inference/ explana4on? How do we learn of causes?

26 Psychology: How do we gain and use causal knowledge? What s the rela4onship between moral and causal judgment? Philosophy: What is a cause? How do we learn of causes? Computer Science: How can we automate inference/ explana4on?

27 What s the rela4onship between moral and causal judgment? Psychology: How do we gain and use causal knowledge? Philosophy: What is a cause? How do we learn of causes? Computer Science: How can we automate inference/ explana4on? Epidemiology: What affects human health? Large- scale analysis of EHRs

28 What s the rela4onship between moral and causal judgment? Psychology: How do we gain and use causal knowledge? Philosophy: What is a cause? How do we learn of causes? Medicine/biology: Applica4ons to neuroscience, genomics Computer Science: How can we automate inference/ explana4on? BNs RCTs Epidemiology: What affects human health? Large- scale analysis of EHRs

29 Why do people behave as they do? Economics: Do policies achieve goals? Granger causality What s the rela4onship between moral and causal judgment? Psychology: How do we gain and use causal knowledge? Philosophy: What is a cause? How do we learn of causes? Medicine/biology: Applica4ons to neuroscience, genomics Computer Science: How can we automate inference/ explana4on? BNs RCTs Epidemiology: What affects human health? Large- scale analysis of EHRs

30 Three main ques4ons What is a cause? Theories of what dis4nguishes them from correla4ons and how we can iden4fy them How can we find causes? Features of causes that allow us to learn about them When can we infer causes? Methods for inference from data Study design Applica4ons to challenging cases

31 Cause Smoking à LC Evidence Probability: are smokers more likely to get lung cancer? Mechanisms: how could smoking plausibly cause LC? Interven4on: If I made people smoke, would they get lung cancer? Methodology

32 CHF progression Stage A High Risk Stage B Asymptoma4c heart failure Stage C Symptoma4c heart failure Stage D Endstage heart failure Pa4ents have: - Hypertension - Coronary artery disease - diabetes - Prior heart adack - LV disfunc4on - Asymptoma4c valvular disease - Structural heart disease - Shortness of breath and fa4gue - Reduced exercise tolerance - Recurrent hospitaliza4on - Marked symptoms at rest despite interven4on Treatments are: - Treat high blood pressure - Encourage exercise Treatments for A plus, some cases - ACE inhibitors - Beta blockers Treatments for A plus: - Salt restric4on - ACE inhibitor - Beta blocker Treatments for A, B, C and: - Heart transplant - Hospice Adapted from ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult Hunt et al. 2001

33 Electronic health record (EHR) data Poten4al Find drug side effects Markers for disease Challenges Cannot do all possible tests Gaps in treatment, change of providers Ambiguity in 4ming Observa4on of symptoms, not disease itself

34 Logic- based causal inference Complex, temporal rela4onships v ; 15,apple g Poten4al causes raise probability of and are earlier than effects P (e c) >P(e) Kleinberg & Mishra (UAI 2009)

35 Which causes are significant? Main idea: looking for beder explana4ons for the effect Assess average difference cause makes to probability of effect " avg (c, e) = P x2x c P (e c ^ x) P (e c ^ x) X\c Determine which ε are sta4s4cally significant

36 Inferring 4ming Instead of accep4ng/rejec4ng hypotheses, refine them from data Can start by tes4ng rela4onships between all variables and CHF in 1-2 weeks, and ul4mately infer "high AST leads to CHF in 4-10 days Kleinberg, S. (2013) Causality, Probability, and Time.

37 Intui4on behind procedure 1) Too wide c 2) Shifted r x s 3) Too narrow actual r' s' " avg (c, e) = P x2x c P (e c ^ x) P (e c ^ x) X\c P (e c ^ x) = #(c ^ x ^ e) #(c ^ x)

38 Name FDR FNR Avg. # itera4ons W W W PWR PWR Note: Total number of FP in W7 is 3, while in PWR4 it is 12, and W27 8. Timing inference start end Name mean med. std. mean med. std. W W W PWR PWR

39 Geisinger CHF data 3,838 cases, 28,843 controls Average of 7 years of data, 86 encounters (2.2 years pre diagnosis) Variables Comorbidities and problem list Vitals (BP, height, weight, pulse, temperature) Medica4ons Lab values

40 Results dx_hypothyroidism dx_diabetes dx_overweight 10 9 first_an4htn_combo 11 8 dx_urinary_symptoms Months before CHF diagnosis

41 Replica4on Geisinger (~32K pa4ents) in PA Stable, rural popula4on 95% white Columbia (~13K pa4ents in AIM clinic) in NY Significant in/out- migra4on, urban 57% white, 28% black, 15% asian S. Kleinberg and N. Elhadad (2013) Lessons Learned in Replica4ng Data- Driven Experiments in Mul4ple Medical Systems and Pa4ent Popula4ons. AMIA Annual Symposium.

42 Data comparison Geisinger popula4on 3,838 cases, 28,843 controls Structured comorbidi4es and problem list Vitals (BP, height, weight, pulse, temperature) Medica4ons Lab values CUMC popula4on 1,853 cases 11,765 controls Medica4on orders ICD9 codes Lab values

43 CHF - CUMC potassium_channel_block PCO2A- cri4cal- low dx_angina dx_copd_asthma ICAI loop_diure4c salicylates heparin an4coag biguanide beta_block thyroid_hormone cardiac_glycosides insulin calcium_block Months before CHF diagnosis

44

45 Result comparison Some common findings Diabetes (insulin) Thyroid dysfunc4on (hypothyroidism, thyroid hormone prescrip4on) Hypertension (an4hypertensive combina4on medica4ons, calcium channel/beta blockers Geisinger onset 4mings likely more accurate, popula4on larger

46 Opera>onal criteria 1 outpa4ent visit or 1 medica4on order 2+ medica4on orders only 2+ outpa4ent visits only 1 outpa4ent visit and 1 medica4on order only Problem list only Meet 2 of 3 criteria Meet all 3 criteria none 1 minor, 0 major Number of Framingham criteria 2+ minor, 0 major 0 minor, 1 major 1 minor, 1 major 1 major, 2+ minor 2+ major Total Meets opera4onal criteria and Framingham criteria, N=2294 (35%) Meets opera4onal criteria but not Framingham criteria, N=2900 (45%) Meets Framingham criteria but not opera4onal criteria, N=424 (7%) Does not meet opera4onal criteria or Framingham criteria, N=879 (14%) Total Wu et al. (2010). Prediction Modeling Using EHR Data: Challenges, Strategies, and a Comparison of Machine Learning Approaches. Med Care 48(6):S

47

48 hdp://discoverysedge.mayo.edu/ar4ficial- pancreas/

49 Uncertain data Error in measurements Missing data Delay Inconsistent 4mescales

50 Discre4za4on 1" 0.9" 0.8" 0.7" 0.6" 0.5" 0.4" 0.3" 0.2" 0.1" 0" 1" 11" 21" 31" 41" 51" 61" 71" 81" 91" 101" 111" 121" 131" 141" 151" 161" 171" 181" 191" 201" 1" 0.9" 0.8" 0.7" 0.6" 0.5" 0.4" 0.3" 0.2" 0.1" 0" 1" 11" 21" 31" 41" 51" 61" 71" 81" 91" 101" 111" 121" 131" 141" 151" 161" 171" 181" 191" 201" hypo" eu" hyper"

51 Adding uncertainty P (e c, x) = P P t ecx t cx P (e c, x) = P P (e, c, x) Pt P (c, x) t D. Hutchison and S. Kleinberg (2013) Causality and Experimenta4on in the Sciences.

52 Causes of changes in glucose Cohort: 17 subjects with T1DM Sensor data (collected for >72 hours) Glucose values Insulin dosage Ac4vity Sleep stage Heart rate Temperature With N. Heintzman (UCSD)

53 Results very vigorous exercise leads to hyperglycemia (fdr <.01) in 5-30 minutes Found using both HR (anaerobic ac4vity zone) and METs Not found with strict discre4za4on Supported by literature (Marliss and Vranic, 2002; Riddell and Perkins, 2006)

54 Rare events Financial markets Twider: 8 TB/day ICU: 5 sec measurements

55 Why not use current methods? Rare event mining No informa4on about impact of events False alarms Causal inference Probabilis4c: can t handle infrequent events Granger: assesses whole 4me series Complexity: efficiency is key with big data

56 Approach Infer normal model Use huge volume of data Find how much is not explained by model Determine how explanatory rare event is Comparing to average dis4nguishes between unmeasured and infrequent events Kleinberg (2013) IJCAI

57 Experiments Simulated financial 4me series data 5 structures [next slide]: 2 with 10 causal rela4onships, 3 with 20 1 or 3 rare causes in each 3 different probabili4es for rare events (0.005, , ) 25 variables 4,000 or 10,000 4me points 480 (5 structures, 3 probabili4es, 4 runs each, 2 types of rare causes, 2 observa4on lengths, 2 4me periods)

58 Structures

59 Results 4,000 4mepoints 10,000 4mepoints

60 Mo data mo problems Big good Uncertainty Selec4on bias Signal:noise Interpreta4on Time Ground truth

61 Open problems (known unknowns) Hidden variables Rela4onships that change over 4me Hypothesis genera4on Es4ma4ng uncertainty Tes4ng assump4ons Automa4ng explana4on

Causal Inference from Complex Observational Data. Samantha Kleinberg Stevens Institute of Technology

Causal Inference from Complex Observational Data. Samantha Kleinberg Stevens Institute of Technology Causal Inference from Complex Observational Data Samantha Kleinberg Stevens Institute of Technology samantha.kleinberg@stevens.edu Three key points We need causal knowledge Causes are hard to find and

More information

Health Informa.cs. Lecture 9. Samantha Kleinberg

Health Informa.cs. Lecture 9. Samantha Kleinberg Health Informa.cs Lecture 9 Samantha Kleinberg samantha.kleinberg@stevens.edu Next week: journal club For all papers: read, and prepare to comment on For your paper: Read the ar.cle (+ other references

More information

Health Informa.cs. Lecture 7. Samantha Kleinberg

Health Informa.cs. Lecture 7. Samantha Kleinberg Health Informa.cs Lecture 7 Samantha Kleinberg samantha.kleinberg@stevens.edu Prac.cali.es: preserving privacy Good prac.ces for preserving privacy Physical security Locked cabinet/office, don t print

More information

Causal Inference: prediction, explanation, and intervention

Causal Inference: prediction, explanation, and intervention Causal Inference: prediction, explanation, and intervention Lecture 1: Introduction Samantha Kleinberg samantha.kleinberg@stevens.edu About me: Samantha Kleinberg PhD in CS Have worked in biomathematics,

More information

A review of approaches to identifying patient phenotype cohorts using electronic health records

A review of approaches to identifying patient phenotype cohorts using electronic health records A review of approaches to identifying patient phenotype cohorts using electronic health records Shivade, Raghavan, Fosler-Lussier, Embi, Elhadad, Johnson, Lai Chaitanya Shivade JAMIA Journal Club March

More information

Identifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems

Identifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems Identifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems Jose Pepe L. Contreras-Vidal, Ph.D. Department of Electrical & Computer

More information

Development and Applica0on of Real- Time Clinical Predic0ve Models

Development and Applica0on of Real- Time Clinical Predic0ve Models Development and Applica0on of Real- Time Clinical Predic0ve Models Ruben Amarasingham, MD, MBA Associate Professor, UT Southwestern Medical Center AHRQ- funded R24 UT Southwestern Center for Pa?ent- Centered

More information

Process of Science and hypothesis tes2ng in Behavioral Ecology

Process of Science and hypothesis tes2ng in Behavioral Ecology Process of Science and hypothesis tes2ng in Behavioral Ecology Goal: understand the way that scien2fic hypotheses and methodologies are used to gain knowledge. What separates science from non- science?

More information

Learning Objec1ves. Study Design Considera1ons in Clinical Pharmacy

Learning Objec1ves. Study Design Considera1ons in Clinical Pharmacy 9/28/15 Study Design Considera1ons in Clinical Pharmacy Ludmila Bakhireva, MD, PhD, MPH Pree Sarangarm, PharmD, BCPS Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal

More information

Learning Objec1ves. Study Design Strategies. Cohort Studies 9/28/15

Learning Objec1ves. Study Design Strategies. Cohort Studies 9/28/15 9/28/15 Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal study designs Explain why the overall study design is important when evalua1ng studies & applying their

More information

Casual Methods in the Service of Good Epidemiological Practice: A Roadmap

Casual Methods in the Service of Good Epidemiological Practice: A Roadmap University of California, Berkeley From the SelectedWorks of Maya Petersen 2013 Casual Methods in the Service of Good Epidemiological Practice: A Roadmap Maya Petersen, University of California, Berkeley

More information

Pragma&c Clinical Trials

Pragma&c Clinical Trials Pragma&c Clinical Trials Susanne May, PhD Associate Professor Department of Biosta&s&cs, School of Public Health, University of Washington Preliminaries PLEASE ask ques&ons at any &me REALLY good clinical

More information

Causal Inference: predic1on, explana1on, and interven1on

Causal Inference: predic1on, explana1on, and interven1on Causal Inference: predic1on, explana1on, and interven1on Lecture : Mechanisms, Interven1ons, and Randomized Controlled Trials Samantha Kleinberg samantha.kleinberg@stevens.edu Blame Who s at fault for

More information

Understanding. Design & Sta/s/cs. in Clinical Trials

Understanding. Design & Sta/s/cs. in Clinical Trials Understanding Design & Sta/s/cs in Clinical Trials 1 Why bother? 2 Experience- Based Medicine? Benjamin Rush Father of American Psychiatry 3 Experience- Based Medicine? Supported blood- lejng as treatment

More information

Decision Support. HAP 752 Advanced Health Informa6on Systems. Janusz Wojtusiak, PhD George Mason University Spring 2014

Decision Support. HAP 752 Advanced Health Informa6on Systems. Janusz Wojtusiak, PhD George Mason University Spring 2014 Decision Support HAP 752 Advanced Health Informa6on Systems Janusz Wojtusiak, PhD George Mason University Spring 2014 Evidence does not make decisions, people do. - Haynes, Devereaux, GuyaQ (BMJ 2002)

More information

Welcome! Pragmatic Clinical Studies. David Hickam, MD, MPH Program Director Clinical Effectiveness Research. David Hickam, MD, MPH

Welcome! Pragmatic Clinical Studies. David Hickam, MD, MPH Program Director Clinical Effectiveness Research. David Hickam, MD, MPH Pragmatic Clinical Studies David Hickam, MD, MPH Program Director Clinical Effec2veness Research June 23, 2015 Welcome! David Hickam, MD, MPH Program Director Clinical Effectiveness Research 2 In this

More information

A R E V I E W O F C A U S A L I N F E R E N C E F O R B I O M E D I C A L I N F O R M AT I C S

A R E V I E W O F C A U S A L I N F E R E N C E F O R B I O M E D I C A L I N F O R M AT I C S A R E V I E W O F C A U S A L I N F E R E N C E F O R B I O M E D I C A L I N F O R M AT I C S samantha kleinberg and george hripcsak Causality is an important concept throughout the health sciences and

More information

Propensity Score Methods for Longitudinal Data Analyses: General background, ra>onale and illustra>ons*

Propensity Score Methods for Longitudinal Data Analyses: General background, ra>onale and illustra>ons* Propensity Score Methods for Longitudinal Data Analyses: General background, ra>onale and illustra>ons* Bob Pruzek, University at Albany SUNY Summary Propensity Score Analysis (PSA) was introduced by Rosenbaum

More information

Genetic Tests and Genetic Counseling How to Analyze Your Own Genome

Genetic Tests and Genetic Counseling How to Analyze Your Own Genome Genetic Tests and Genetic Counseling 02-223 How to Analyze Your Own Genome Genetic Tests for Huntington Disease Hun7ngton Disease Incurable brain disorder that runs in families Movement, cogni7ve, and

More information

Discordant MIC Analysis: Tes5ng for Superiority within a Non- inferiority Trial

Discordant MIC Analysis: Tes5ng for Superiority within a Non- inferiority Trial Discordant MIC Analysis: Tes5ng for Superiority within a Non- inferiority Trial Dean Follmann, Erica BriDain, and John Powers Na5onal Ins5tute of Allergy and Infec5ous Diseases November 19, 2014 1 Current

More information

Common Data Elements: Making the Mass of NIH Measures More Useful

Common Data Elements: Making the Mass of NIH Measures More Useful Common Data Elements WG Common Data Elements: Making the Mass of NIH Measures More Useful Jerry Sheehan Assistant Director for Policy Development Na?onal Library of Medicine Gene/c Alliance Webinar Series

More information

The Moral Psychology Simplexity of Acceptable Risk in Safety Standards

The Moral Psychology Simplexity of Acceptable Risk in Safety Standards The Moral Psychology Simplexity of Acceptable Risk in Safety Standards by Andreas Johnsen andreas.johnsen@mdh.se April, 2016 Safety-critical systems Certification through safety standards Safety of electrical

More information

Economic outcomes: Method for implementa5on

Economic outcomes: Method for implementa5on Economic outcomes: Method for implementa5on Philippe Beutels Centre for Health Economics Research & Modelling Infec

More information

Characteriza*on of Soma*c Muta*ons in Cancer Genomes

Characteriza*on of Soma*c Muta*ons in Cancer Genomes Characteriza*on of Soma*c Muta*ons in Cancer Genomes Ben Raphael Department of Computer Science Center for Computa*onal Molecular Biology Soma*c Muta*ons and Cancer Clonal Theory (Nowell 1976) Passenger

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author(s): Rajesh Mangrulkar, M.D., 2013 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-commercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

More information

Use and Interpreta,on of LD Score Regression. Brendan Bulik- Sullivan PGC Stat Analysis Call

Use and Interpreta,on of LD Score Regression. Brendan Bulik- Sullivan PGC Stat Analysis Call Use and Interpreta,on of LD Score Regression Brendan Bulik- Sullivan bulik@broadins,tute.org PGC Stat Analysis Call Outline of Talk Intui,on, Theory, Results LD Score regression intercept: dis,nguishing

More information

Recording ac0vity in intact human brain. Recording ac0vity in intact human brain

Recording ac0vity in intact human brain. Recording ac0vity in intact human brain Recording ac0vity in intact human brain Recording ac0vity in intact human brain BIONB 4910 April 8, 2014 BIONB 4910 April 8, 2014 Objec0ves: - - review available recording methods EEG and MEG single unit

More information

CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL?

CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL? CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL? Mette Nørgaard, Professor, MD, PhD Department of Clinical Epidemiology Aarhus Universitety Hospital Aarhus, Denmark Danish Medical Birth Registry

More information

Sta$s$cs is Easy. Dennis Shasha From a book co- wri7en with Manda Wilson

Sta$s$cs is Easy. Dennis Shasha From a book co- wri7en with Manda Wilson Sta$s$cs is Easy Dennis Shasha From a book co- wri7en with Manda Wilson Is the Coin Fair? You toss a coin 17 $mes and it comes up heads 15 out of 17 $mes. How likely is it that coin is fair? Could look

More information

Sets, Logic, and Probability As Used in Decision Support Systems

Sets, Logic, and Probability As Used in Decision Support Systems Sets, Logic, and Probability As Used in Decision Support Systems HAP 752 Advanced Health Informa6on Systems Janusz Wojtusiak, PhD George Mason University Spring 2014 Part of the inhumanity of the computer

More information

Causes of variability in developmental disorders

Causes of variability in developmental disorders Causes of variability in developmental disorders Is the medical risk model appropriate for understanding behavioural deficits? Michael Thomas Birkbeck College Workshop: Developmental disorders: co- morbidity,

More information

Aggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results

Aggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results Aggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results Disclosures Funding by NINDS U01 NS058728 Boston Scien8fic provided

More information

Malnutri)on Universal Screening Tool (MUST)

Malnutri)on Universal Screening Tool (MUST) Malnutri)on Universal Screening Tool () Nutri&on screening mandated in acute care se1ngs in the US, UK and Canada - Iden&fy malnourished pa&ents and those at risk à warrant more detailed assessment/treatment

More information

Public Health / Public Works Introduc6on, reitera6on + Lessons 1-2. Pioneer Winter IDH 3034, IDH 4007

Public Health / Public Works Introduc6on, reitera6on + Lessons 1-2. Pioneer Winter IDH 3034, IDH 4007 Public Health / Public Works Introduc6on, reitera6on + Lessons 1-2 Pioneer Winter IDH 3034, IDH 4007 What s the purpose of this class? Learning Objec6ves Understand the principles of public health, epidemiology,

More information

Considera*ons when undergoing personal genotyping

Considera*ons when undergoing personal genotyping Considera*ons when undergoing personal genotyping Kelly Ormond, MS, CGC Louanne Hudgins, MD, FACMG January 19, 2011 GENE 210 Disclosures and introduc*ons Professor Ormond provided paid consulta*on for

More information

6/20/18. Prac+cum #1 Wednesday 6/27. Lecture Ques+on. Quick review. Establishing Causality. Causality

6/20/18. Prac+cum #1 Wednesday 6/27. Lecture Ques+on. Quick review. Establishing Causality. Causality 6//8 Prac+cum # Wednesday 6/7 Agenda I. II. III. Reliability and Validity IV.Introduc6on to SPSS PART A (Paper-and-pencil 8 points) 3 short answer ques6ons (6 points each) mul+ple choice ques6ons (3 points

More information

Applica(on of Causal Inference Methods to Improve Treatment of HIV in Resource Limited Se?ngs

Applica(on of Causal Inference Methods to Improve Treatment of HIV in Resource Limited Se?ngs Applica(on of Causal Inference Methods to Improve Treatment of HIV in Resource Limited Se?ngs Maya Petersen works.bepress.com/maya_petersen Divisions of Biosta,s,cs and Epidemiology, University of California,

More information

Chronic Kidney Disease

Chronic Kidney Disease Chronic Kidney Disease Management Issues in the Hospital and Beyond in pre dialysis CKD pa;ents Brian Wolfe, MD Assistant Professor of Medicine University of Colorado Denver, Hospital Medicine Sec;on Case:

More information

OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP

OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP OBSERVATIONAL Patient-centered observational analytics: New directions toward studying the effects of medical products Patrick Ryan on behalf of OMOP Research Team May 22, 2012 Observational Medical Outcomes

More information

Engage and Empower Pa.ents with Interac.ve Technology. Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012

Engage and Empower Pa.ents with Interac.ve Technology. Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012 Engage and Empower Pa.ents with Interac.ve Technology Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012 NAHAM - Pa.ent Access Services 2 Pa%ent Access Services

More information

A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons?

A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons? A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons? Michael Hogarth, MD, FACP CMIO, Athena Breast Health Network Professor,

More information

The Role of PCP in Prostate Cancer Screening Beaver Creek Ma< T. Rosenberg

The Role of PCP in Prostate Cancer Screening Beaver Creek Ma< T. Rosenberg The Role of PCP in Prostate Cancer Screening Beaver Creek 2017 Ma< T. Rosenberg A Cri@cal Look at the Historical Flow Pa@ent concern Office visit History DRE PSA Biopsy Specimen with pathologist Too Many

More information

Propensity Score. Overview:

Propensity Score. Overview: Propensity Score Overview: What do we use a propensity score for? How do we construct the propensity score? How do we implement propensity score es

More information

A Transla)onal Framework for Methodological Rigor to Improve Pa)ent Centered Outcomes in End of Life Cancer Research

A Transla)onal Framework for Methodological Rigor to Improve Pa)ent Centered Outcomes in End of Life Cancer Research A Transla)onal Framework for Methodological Rigor to Improve Pa)ent Centered Outcomes in End of Life Cancer Research Francesca Dominici, PhD Senior Associate Dean for Research Professor of Biostatistics

More information

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza Aeron Hurt WHO Collabora@ng Centre for Reference and Research on Influenza, Melbourne, Australia www.influenzacentre.org NA inhibitor

More information

Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data

Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data Kaelber, et al, JAMIA, 3 July 2012 David C Kaelber, MD, PhD, MPH, FAAP, FACP

More information

Journée d étude du Cogmaster Good (and less good) lab prac8ces

Journée d étude du Cogmaster Good (and less good) lab prac8ces Journée d étude du Cogmaster Good (and less good) lab prac8ces Saturday 25 octobre 2014 9h30 10h30: overview of lab prac8ces 11h30 15h30 Lab Notebook 11h35 11h55: summarizing/clarifying the notebook 11h55

More information

Right Answers, Wrong Ques2ons. Ralph I Horwitz

Right Answers, Wrong Ques2ons. Ralph I Horwitz Right Answers, Wrong Ques2ons Ralph I Horwitz Disclosures Employed by GlaxoSmithKline Views expressed reflect mine alone and not those of GSK Right Answer, Wrong Ques2on A young couple moves into an apartment

More information

Which Figure Is It? (Geometry) ANNOTATED STUDENT WORK SAMPLE ARGUMENTATION RESOURCE PACKET

Which Figure Is It? (Geometry) ANNOTATED STUDENT WORK SAMPLE ARGUMENTATION RESOURCE PACKET Which Figure Is It? (Geometry) ANNOTATED STUDENT WORK SAMPLE ARGUMENTATION RESOURCE PACKET Important note: The teachers and project members that discussed these work samples were not always unanimous in

More information

3/31/2015. Designing Clinical Research Studies: So You Want to Be an

3/31/2015. Designing Clinical Research Studies: So You Want to Be an Designing Clinical Research Studies: So You Want to Be an Inves@gator Andrea Bonny, MD Ellen Lançon Connor, MD On behalf Of The NASPAG Research CommiPee Objec@ves Learn to design a clinical research project

More information

Locke s Inverted Spectra

Locke s Inverted Spectra Locke s Inverted Spectra Neither would it carry any Imputa:on of Falshood to our simple Ideas, if by the different Structure of our Organs, it were so ordered, That the same Object should produce in several

More information

Perspec'vas Psicologicas en el Cuidado de la Diabetes

Perspec'vas Psicologicas en el Cuidado de la Diabetes Perspec'vas Psicologicas en el Cuidado de la Diabetes Antonio E. Puente University of North Carolina Wilmington Universidad de la Ciudad de Juarez 09.20.13 Health Sta's'cs: 2010 (The Economist, 12.12.09)

More information

An Introduc+on to Stroke

An Introduc+on to Stroke An Introduc+on to Stroke Elizabeth Huntoon MS, MD Assistant Professor Department of Physical Medicine and Rehabilita>on Vanderbilt University School of Medicine Defini+on Sudden focal neurologic deficit

More information

Clinical Research Project Design and Guidelines: Choosing a Research Ques8on

Clinical Research Project Design and Guidelines: Choosing a Research Ques8on Clinical Research Project Design and Guidelines: Choosing a Research Ques8on Odunayo M. Oluwatosin, FMCS (Nig) Department of Plas?c Surgery University College Hospital Ibadan 1 Learning outcome: by the

More information

In this module we will cover Correla4on and Validity.

In this module we will cover Correla4on and Validity. In this module we will cover Correla4on and Validity. A correla4on coefficient is a sta4s4c that is o:en used as an es4mate of measurement, such as validity and reliability. You will learn the strength

More information

Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines.

Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines. Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines Chris,ne McDonough, PhD, PT, CEEAA Health Outcomes Unit Department of Health

More information

Nova StatStrip Blood Glucose Meter Re-Cer7fica7on 2017

Nova StatStrip Blood Glucose Meter Re-Cer7fica7on 2017 SUNY Downstate Medical Center University Hospital of Brooklyn Point of Care Laboratory & Department of Nursing Services Ins7tute of Con7nuous Learning Nova StatStrip Blood Glucose Meter Re-Cer7fica7on

More information

Cardiovascular Effects of ADT in

Cardiovascular Effects of ADT in Cardiovascular Effects of ADT in Click to edit Prostate Master Cancer /tle style Pa/ents Chris Plummer Freeman Hospital, Newcastle upon Tyne, UK Newcastle University Bri/sh Cardio- Oncology Society Click

More information

A Func'onal Approach to Hypothyroidism Part 1 of 3. Jim Paole*, BS Pharmacy, FAARFM, FIACP

A Func'onal Approach to Hypothyroidism Part 1 of 3. Jim Paole*, BS Pharmacy, FAARFM, FIACP A Func'onal Approach to Hypothyroidism Part 1 of 3 Jim Paole*, BS Pharmacy, FAARFM, FIACP Objec&ves Review the produc/on, metabolism, and ac/vi/es of the thyroid gland and thyroid hormones Differen/ate

More information

Psychological outcomes of cri2cal illness for pa2ents and family members. Erin K. Kross, MD Summer Lung Day June 18, 2010

Psychological outcomes of cri2cal illness for pa2ents and family members. Erin K. Kross, MD Summer Lung Day June 18, 2010 Psychological outcomes of cri2cal illness for pa2ents and family members Erin K. Kross, MD Summer Lung Day June 18, 2010 Outline Overview of psychological outcomes for pa2ents and family members ager cri2cal

More information

Check out these helpful videos about use of mask and spacer in children

Check out these helpful videos about use of mask and spacer in children Asthma Asthma What is wheezing? Wheezing is a high-pitched whistling sound made while you breathe. Wheezing is caused by inflamma!on of the small airways and can have a variety of different underlying

More information

The COUNTER HF Clinical Study for Heart Failure

The COUNTER HF Clinical Study for Heart Failure The COUNTER HF Clinical Study for Heart Failure CAUTION: C- Pulse is an inves?ga?onal device. It is limited by Federal (or United States) Law to inves?ga?onal use only. It is not available for sale in

More information

A large database study in the general population in England

A large database study in the general population in England Time-dependent markers of comorbidity severity and change are associated with increased risk of mortality in heart failure: A large database study in the general population in England Claire A. Rushton,

More information

Therapy following DRF Yes or No?

Therapy following DRF Yes or No? Distal Radius Fractures Rehabilita6on & Ortho6c Selec6on Do you think outcomes will be the same? 1 2 Therapy following DRF Yes or No? Evidence for Therapy following DRF Level I: Systema6c Review (Handoll,

More information

THE FRONT- LINE LEADER S INTERPRETATION OF EMOTIONAL INTELLIGENCE SKILLS. Tanya O Neill, Psy.D. April 2016

THE FRONT- LINE LEADER S INTERPRETATION OF EMOTIONAL INTELLIGENCE SKILLS. Tanya O Neill, Psy.D. April 2016 THE FRONT- LINE LEADER S INTERPRETATION OF EMOTIONAL INTELLIGENCE SKILLS Tanya O Neill, Psy.D. April 2016 INTRODUCTION Emo

More information

Local EBQ Course - PERU Epidemiology, Biostatistics & Qualitative Research Methods

Local EBQ Course - PERU Epidemiology, Biostatistics & Qualitative Research Methods , Biostatistics & 20 places available Iquitos, Peru Apply now for this 3-week course! Applica7on procedure and criteria for academic eligibility and funding can be found on www.uantwerp.be/ebq-peru Deadline

More information

Department of Emergency Office of Research. Shannon McNabb, MA, MPH Clinical Research Manager January 2017

Department of Emergency Office of Research. Shannon McNabb, MA, MPH Clinical Research Manager January 2017 Department of Emergency Medicine Office of Research Shannon McNabb, MA, MPH Clinical Research Manager January 2017 EM Study Tracking System UPDATED ON: 12/5/2016 TOTAL 68 Grants Submitted, Award Pending

More information

Developing targeted therapies for neurodevelopmental and neurodegenerative diseases

Developing targeted therapies for neurodevelopmental and neurodegenerative diseases Developing targeted therapies for neurodevelopmental and neurodegenerative diseases Clinical Pharmacokine/cs and Pharmacodynamics Characteriza/on of ANAVEX 2-73 for Designing a Phase 2/3 Study in Mild-to-Moderate

More information

Management of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist

Management of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist Management of Acute Ischemic Stroke Jen Simpson Neurohospitalist Learning Objec=ves Iden=fy signs/symptoms of stroke Recognize pa=ents who may be eligible for treatment of acute stroke What is a Stroke?

More information

Paget s Disease of Bone

Paget s Disease of Bone Paget s Disease of Bone Copyright Copyright 2019 American 2019 American Associa7on Associa7on of Clinical of Clinical Endocrinologists Endocrinologists 1 A Common Bone Disorder Paget s disease of bone

More information

Designing and Delivering ACT Interven2ons for Individuals with Medical Condi2ons:

Designing and Delivering ACT Interven2ons for Individuals with Medical Condi2ons: ACBS Symposium World Con 12 Designing and Delivering ACT Interven2ons for Individuals with Medical Condi2ons: Transdiagnos2c principles and key change processes Megan Oser, PhD Vanessa Alvarez, MA Gabe

More information

Common Causes of Hypothyroidism

Common Causes of Hypothyroidism Common Causes of Hypothyroidism Autoimmune thyroidi4s Surgical removal of thyroid gland Medica4on Therapy Iodine and iodine containing medica4ons Neck radia4on Post Partum thyroidi4s Prevalence of Hypothyroidism

More information

What Are Neuroscience Core Concepts?

What Are Neuroscience Core Concepts? What Are Neuroscience Core Concepts? Neuroscience Core Concepts offer fundamental principles that one should know about the brain and nervous system, the most complex living structure knowing in the universe.

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

speakers! Jeffrey E. Shuren MD, JD Steven Immergut MPH Janet Woodcock MD Margaret Anderson Director, Center for Drug Evaluation and Research

speakers! Jeffrey E. Shuren MD, JD Steven Immergut MPH Janet Woodcock MD Margaret Anderson Director, Center for Drug Evaluation and Research Key FDA Programs! Objective: Describe FDA initiatives at CDER and CDRH to incorporate patient perspectives in decision-making and to articulate assessment of benefit-risk in a consistent manner across

More information

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010 Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010 C.J.Vaske et al. May 22, 2013 Presented by: Rami Eitan Complex Genomic

More information

Frailty in Geriatric Trauma Pa1ents

Frailty in Geriatric Trauma Pa1ents Division of Trauma, Burn, Surgical Critical Care, & Emergency General Surgery Frailty in Geriatric Trauma Pa1ents Zara Cooper, MD, MSc, FACS Elizabeth Bryant, MPH Disclosures NIA R01AG044518 NCI R35CA197730

More information

Pa#ern recogni,on and neuroimaging in psychiatry

Pa#ern recogni,on and neuroimaging in psychiatry Pa#ern recogni,on and neuroimaging in psychiatry Janaina Mourao-Miranda Machine Learning and Neuroimaging Lab Max Planck UCL Centre for Computa=onal Psychiatry and Ageing Research Outline Supervised learning

More information

Forward Looking Statements

Forward Looking Statements March 12, 2015 1 Forward Looking Statements This presenta5on contains forward- looking statements within the meaning of the Private Securi5es Li5ga5on Reform Act of 1995 that involve substan5al risks and

More information

Should Me*ormin be contraindicated in pa4ents with CKD? TAYLOR MCBRIDE UNIVERSITY OF TEXAS/HEB PGY-1 COMMUNITY PHARMACY RESIDENT

Should Me*ormin be contraindicated in pa4ents with CKD? TAYLOR MCBRIDE UNIVERSITY OF TEXAS/HEB PGY-1 COMMUNITY PHARMACY RESIDENT Should Me*ormin be contraindicated in pa4ents with CKD? TAYLOR MCBRIDE UNIVERSITY OF TEXAS/HEB 2018-2019 PGY-1 COMMUNITY PHARMACY RESIDENT 1 Objec4ves Understand the changes to Me*ormin labeled use in

More information

Preven'ng AKI. Lessons from Contrast-associated AKI It s all about urine output

Preven'ng AKI. Lessons from Contrast-associated AKI It s all about urine output Preven'ng AKI Lessons from Contrast-associated AKI It s all about urine output CASE A 76 y/o male comes to the ED complaining of substernal crushing chest pain. The pain started a few hours ago while he

More information

Applying STPA to the Artificial Pancreas for People with Type 1 Diabetes

Applying STPA to the Artificial Pancreas for People with Type 1 Diabetes Applying STPA to the Artificial Pancreas for People with Type 1 Diabetes Lane Desborough Product Strategist Medtronic Diabetes Northridge, California Type 1 Diabetes Artificial Pancreas Challenges Applying

More information

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN** Documentation and coding guide Disease definitions* HTN is diagnosed when the average of two or more (systolic of diastolic) blood pressure readings are found to be elevated on two or more office visits

More information

Assessment of ANAVEX 2-73 in a MECP2 Re5 Syndrome Mouse Model

Assessment of ANAVEX 2-73 in a MECP2 Re5 Syndrome Mouse Model Assessment of ANAVEX 2-73 in a MECP2 Re5 Syndrome Mouse Model 2016 Epilepsy Pipeline Conference February 26 th 2016 Safe Harbor This presenta,on contains forward- looking statements made within the meaning

More information

Action observation and action imagination: from pathology to the excellent sport performance

Action observation and action imagination: from pathology to the excellent sport performance Action observation and action imagination: from pathology to the excellent sport performance Imita'on Meltzoff & Moore, Science 1977 Rizzola8 and the Parma s group: The mirror system Open problems for

More information

emeasure Title emeasure Identifier (Measure Authoring Tool) 621 emeasure Version number

emeasure Title emeasure Identifier (Measure Authoring Tool) 621 emeasure Version number emeasure Title emeasure Identifier (Measure Authoring Tool) Measurement That Matters 621 emeasure Version number 0.0.013 NQF Number GUID a81691e2-4be1-4725-b279- a07448a74bcd Measurement Period Measure

More information

10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities

10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities 10/26/15 Perspec'ves on maternal opioid use and abuse Dr. Rita J. Nutt Our Expectation Harsh Realities 1 Opioid Abuse and Dependence Statistics, 2013 4.5 million people in the US current non- medical users

More information

Surviving Sepsis and Stewardship

Surviving Sepsis and Stewardship Surviving Sepsis and Stewardship Start Smart Then Focus Are these hopelessly compe5ng objec5ves? Dr David R Jenkins, Consultant Medical Microbiologist and Infec>on Control Doctor, University Hospitals

More information

Metabolically Healthy Obese:

Metabolically Healthy Obese: Metabolically Healthy Obese: Reality or Fantasy? Mercedes Carnethon, Ph.D., FAHA Associate Professor, Department of Preven:ve Medicine Feinberg School of Medicine at Northwestern University May 15, 2014

More information

Study Design STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL STUDY DESIGN

Study Design STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL STUDY DESIGN STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL Daniel E. Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine Introduction to Clinical Research July 15, 2014 STUDY DESIGN Provides

More information

Key Statistical Considerations. Dr Delva Shamley

Key Statistical Considerations. Dr Delva Shamley Key Statistical Considerations Dr Delva Shamley WHAT STATISTICAL INFORMATION DO YOU NEED FOR A RESEARCH PROJECT? 1. Sample Size 2. Details of the type of data you will get from your outcome measures 3.

More information

Agenda. Clinical and Operational Considerations for Appropriate Telepsychiatry Best Prac/ces for Designing and Implemen/ng Telebehavioral Health

Agenda. Clinical and Operational Considerations for Appropriate Telepsychiatry Best Prac/ces for Designing and Implemen/ng Telebehavioral Health Clinical and Operational Considerations for Appropriate Telepsychiatry Best Prac/ces for Designing and Implemen/ng Telebehavioral Health RCPA- Fall 2014 Geoffrey Boyce, MBA Execu/ve Director InSight James

More information

USING EVIDENCE FOR HEMATOLOGY LABORATORY PRACTICE. Alfonso Iorio McMaster University, Canada

USING EVIDENCE FOR HEMATOLOGY LABORATORY PRACTICE. Alfonso Iorio McMaster University, Canada USING EVIDENCE FOR HEMATOLOGY LABORATORY PRACTICE Alfonso Iorio McMaster University, Canada Disclosures Financial No relevant rela1onships to disclose Research funding in the field of hemophilia care Intellectual

More information

Conflicts of interest. Objec5ves / Outline. Pulmonary rehabilita5on. Pulmonary rehabilita5on in COPD. Pulmonary rehabilita5on in COPD 11/26/13

Conflicts of interest. Objec5ves / Outline. Pulmonary rehabilita5on. Pulmonary rehabilita5on in COPD. Pulmonary rehabilita5on in COPD 11/26/13 Conflicts of interest UBC I have no conflicts of interest related to this presenta5on Treatment op+ons From a global perspec+ve: Non- pharmaceu+cal treatments Pulmonary Fibrosis Founda5on Summit La Jolla,

More information

Hypertension and Atrial Fibrillation

Hypertension and Atrial Fibrillation Hypertension and Atrial Fibrillation Sheldon Tobe MD, MScCH (HPTE), FRCPC, FACP, FASH Hypertension and Nephrology HSF/NOSM Chair in Aboriginal and Rural Health Research Professor in Medicine, University

More information

Operant Condi-oning. Cogni-on and Problem Solving. Cogni-on and Problem Solving. Cogni-on. a process of knowing

Operant Condi-oning. Cogni-on and Problem Solving. Cogni-on and Problem Solving. Cogni-on. a process of knowing Operant condi-oning a type of associa,ve learning in which an animal learns to associate one of its behaviors with a reward or punishment It is also called trial- and- error learning Example a rat that

More information

Research Design. Beyond Randomized Control Trials. Jody Worley, Ph.D. College of Arts & Sciences Human Relations

Research Design. Beyond Randomized Control Trials. Jody Worley, Ph.D. College of Arts & Sciences Human Relations Research Design Beyond Randomized Control Trials Jody Worley, Ph.D. College of Arts & Sciences Human Relations Introduction to the series Day 1: Nonrandomized Designs Day 2: Sampling Strategies Day 3:

More information

Online Workshop: Qualitative Research Synthesis. Karin Hannes, KU Leuven Methodology of Educational Sciences Research Group

Online Workshop: Qualitative Research Synthesis. Karin Hannes, KU Leuven Methodology of Educational Sciences Research Group Center on Knowledge Translation for Disability and Rehabilitation Research Online Workshop: Qualitative Research Synthesis Session 1: Introduction to Reviewing and Synthesizing Qualitative Evidence Karin

More information

What the Cardiac Surgeon can offer General Prac5ce

What the Cardiac Surgeon can offer General Prac5ce What the Cardiac Surgeon can offer General Prac5ce Malcolm Dalrymple- Hay FRCS FECTS PhD Consultant Cardiac Surgeon INTRODUCTION Heart Valve Disease Aor5c Mitral Coronary Surgery (CABG) Pa5ent Pathway,

More information

Predictive Models for Making Patient Screening Decisions

Predictive Models for Making Patient Screening Decisions Predictive Models for Making Patient Screening Decisions MICHAEL HAHSLER 1, VISHAL AHUJA 1, MICHAEL BOWEN 2, AND FARZAD KAMALZADEH 1 1 Southern Methodist University, 2 UT Southwestern Medical Center and

More information